id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2020-E-2337-0008,FDA,FDA-2020-E-2337,Letter from U.S. Patent and Trademark Office to CDER,Other,Letter(s),2024-03-25T04:00:00Z,2024,3,2024-03-25T04:00:00Z,,2024-03-25T22:56:01Z,,0,0,0900006486469ce5
FDA-2020-E-2337-0007,FDA,FDA-2020-E-2337,Letter from FDA CDER to U.S.  Patent and Trademark Office,Other,Letter(s),2024-01-25T05:00:00Z,2024,1,2024-01-25T05:00:00Z,,2024-01-25T14:48:00Z,,0,0,09000064863c1fa1